2024-514146-37-00已完成4 期
Open-label, randomized, two-treatment, two-period, two-sequence, cross-over, single dose, bioequivalence study comparing ISOPRINOSINE® FORTE 100 mg/mL Syrup to ISOPRINOSINE® 500 mg tablets in healthy male and female subjects under fasting conditions.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Ewopharma AG
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Suzanne Curran
Scientific
Ewopharma AG
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Bioavailability study of Curcuminoids capsules of Triokka Pharmaceuticals Private Limited, India with Meriva-SR of Throne Research Inc., USA in 8 Healthy adult human male subjects under fasting conditions.CTRI/2016/05/006938Troikaa Pharmaceuticals Limited8
已完成
1 期
A clinical trial to compare the effects of two drugs, Peginterferon alpha 2 b 1 microgram/kg of M/s. Cadila Healthcare Ltd and Viraferon Peg containing 1 microgram/kg Peginterferon alpha 2 b of Schering Plough in healthy volunteersCTRI/2010/091/001220Cadila Healthcare Limited, Zydus Tower, Satellite Road, Ahmedabad, Gujarat50
已完成
不适用
A clinical trial intended to compare Bioequivalence of two formulations of Risperidone Long Acting Injection 25 mg in patients with Schizophrenia.CTRI/2021/03/031752anomi BV a Lupin group company94
尚未招募
1 期
An open label, randomized, two-treatment, two-period, two-sequence, single oral dose, crossover, bioequivalence study of Ticagrelor tablets 90 mg of Dr. Reddy laboratories limited comparing with that of BRILINTA (film coated tablets) 90 mg in healthy, adult, human subjects under fasting conditionsHealthy subjectsBioequivalence TicagrelorTCTR20210804005Bio-innova and Synchron.Co.,Ltd30
已完成
不适用
A clinical trial to study the pharmacokinetics and pharmacodynamics of Interferon beta 1 b compared with Betaferon, in healthy, adult, male, human subjects.CTRI/2011/12/002221Cadila Healthcare Limited28